Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: A link to major depressive disorder

Neuropsychopharmacology

Volumn 37, Issue 6, 2012, Pages 1548-1557

  Plante, David T ^a   Jensen, J Eric ^b,c   Schoerning, Laura ^d   Winkelman, John W ^c,e  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MCLEAN HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Sleep HealthCenters   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

anterior cingulate cortex; GABA; insomnia; magnetic resonance spectroscopy; occipital cortex; sleep disorders

Indexed keywords

4 AMINOBUTYRIC ACID; CREATINE;

ADULT; ANTERIOR CINGULATE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HUMAN; INSOMNIA; MAJOR DEPRESSION; MALE; OCCIPITAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THALAMUS; VOXEL BASED MORPHOMETRY;

ACTIGRAPHY; ADULT; BRAIN MAPPING; CASE-CONTROL STUDIES; CREATINE; DEPRESSIVE DISORDER, MAJOR; FEMALE; GAMMA-AMINOBUTYRIC ACID; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OCCIPITAL LOBE; PROTONS; RETROSPECTIVE STUDIES; SLEEP INITIATION AND MAINTENANCE DISORDERS; YOUNG ADULT;

EID: 84859783895     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.4     Document Type: Article

References (71)

1. Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U et al (2011). Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord 135: 10-19.
2. Bajbouj M, Lisanby SH, Lang UE, Danker-Hopfe H, Heuser I, Neu P (2006). Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol Psychiatry 59: 395-400. (Pubitemid 43289217)
3. Beck AT, Steer RA (1993). Manual for the Beck Depression Inventory. Psychological Corporation: San Antonio, TX.
4. Behar KL, Rothman DL, Petersen KF, Hooten M, Delaney R, Petroff OA et al (1999). Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry 156: 952-954. (Pubitemid 29260355)
5. Beebe DW, Gozal D (2002). Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. J Sleep Res 11: 1-16. (Pubitemid 34227209)
6. Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Ashworth F, Sule A et al (2007). Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication free recovered unipolar depressed and bipolar subjects. Biol Psychiatry 61: 806-812. (Pubitemid 46330250)
7. Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Boorman E, Matthews PM et al (2008). Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients. Int J Neuropsychopharmacol 11: 255-260. (Pubitemid 351231824)
8. Bogner W, Gruber S, Doelken M, Stadlbauer A, Ganslandt O, Boettcher U et al (2010). In vivo quantification of intracerebral GABA by single-voxel (1)H-MRS-How reproducible are the results? Eur J Radiol 73: 526-531.
9. Bonnet MH, Arand DL (2010). Hyperarousal and insomnia: state of the science. Sleep Med Rev 14: 9-15.
10. Breslau N, Roth T, Rosenthal L, Andreski P (1996). Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 39: 411-418. (Pubitemid 26124560)
11. Buysse DJ (2008). Chronic insomnia. Am J Psychiatry 165: 678-686.
12. Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM (2006). Recommendations for a standard research assessment of insomnia. Sleep 29: 1155-1173. (Pubitemid 44484809)
13. Buysse DJ, Angst J, Gamma A, Ajdacic V, Eich D, Rossler W (2008). Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 31: 473-480. (Pubitemid 351694269)
14. Buysse DJ, Reynolds III CF, Monk TH, Berman SR, Kupfer DJ (1989). The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28: 193-213. (Pubitemid 19144991)
15. Buysse DJ, Reynolds III CF, Hauri PJ, Roth T, Stepanski EJ, Thorpy MJ et al (1994). Diagnostic concordance for DSM-IV sleep disorders: a report from the APA/NIMH DSM-IV field trial. Am J Psychiatry 151: 1351-1360. (Pubitemid 24281761)
16. Cano G, Mochizuki T, Saper CB (2008). Neural circuitry of stressinduced insomnia in rats. J Neurosci 28: 10167-10184.
17. Chang PP, Ford DE, Mead LA, Cooper-Patrick L, Klag MJ (1997). Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol 146: 105-114.
18. Edinger JD, Means MK, Carney CE, Krystal AD (2008). Psychomotor performance deficits and their relation to prior nights0 sleep among individuals with primary insomnia. Sleep 31: 599-607. (Pubitemid 351694248)
19. Epperson CN, Haga K, Mason GF, Sellers E, Gueorguieva R, Zhang W et al (2002). Cortical g-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder A 1H-MRS study. Arch Gen Psychiatry 59: 851-858. (Pubitemid 35001151)
20. Epperson CN, O'Malley S, Czarkowski KA, Gueorguieva R, Jatlow P, Sanacora G et al (2005). Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biol Psychiatry 57: 44-48. (Pubitemid 39647590)
21. Evans CJ, McGonigle DJ, Edden RA (2010). Diurnal stability of gaminobutyric acid concentration in visual and sensorimotor cortex. J Magn Reson Imaging 31: 204-209.
22. Ford DE, Kamerow DB (1989). Epidemiologic study of sleep disturbance and psychiatric disorders: an opportunity for prevention? JAMA 262: 1479-1484. (Pubitemid 19220042)
23. Geramita M, Van der Veen JW, Barnett AS, Savostyanova AA, Shen J, Weinberger DR et al (2011). Reproducibility of prefrontal yaminobutyric acid measurements with J-edited spectroscopy. NMR Biomed 24: 1089-1098.
24. Goddard AW, Mason GF, Almai A, Rothman DL, Behar KL, Petroff OA et al (2001). Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. Arch Gen Psychiatry 58: 556-561. (Pubitemid 32523735)
25. Gold B, Bowers MB, Roth RH, Sweeney DW (1980). GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry 137: 362-364. (Pubitemid 10155047)
26. Gos T, Günther K, Bielau H, Dobrowolny H, Mawrin C, Trübner K et al (2009). Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-immunorective neuropil. J Affect Disord 113: 45-55.
27. Gottesman II, Gould TD (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160: 636-645. (Pubitemid 41079594)
28. Gottesmann C (2002). GABA mechanisms and sleep. Neuroscience 111: 231-239. (Pubitemid 34442609)
29. Hasler G, Neumeister A, van der Veen JW, Tumonis T, Bain EE, Shen J et al (2005). Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy. Biol Psychiatry 58: 969-973. (Pubitemid 41790707)
30. Hasler G, Northoff G (2011). Discovering imaging endophenotypes for major depression. Mol Psychiatry 16: 604-619.
31. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC (2007). Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64: 193-200. (Pubitemid 46220776)
32. Henry ME, Lauriat T, Shanahan M, Renshaw PF, Jensen JE (2011). Accuracy and stability of measuring GABA, glutamate, and glutamine by proton magnetic resonance spectroscopy: a phantom study at 4 Tesla. J Magn Reson 208: 210-218.
33. Kakeda S, Korogi Y, Moriya J, Ohnari N, Sato T, Ueno S et al (2011). Influence of work shift on glutamic acid and gammaaminobutyric acid (GABA): evaluation with proton magnetic resonance spectroscopy at 3T. Psychiatry Res 192: 55-59.
34. Karolewicz B, Maciag D, O'Dwyer G, Stockmeier CA, Rajkowska G (2010). Reduced Level of Glutamic Acid Decarboxylase-67 kDa in the Prefrontal Cortex in Major Depression. Int J Neuropsychopharmacol 13: 411-420.
35. Klumpers UM, Veltman DJ, Drent ML, Boellaard R, Comans EF, Meynen G et al (2010). Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results. Eur J Nucl Med Mol Imaging 37: 565-574.
36. Lefaucheur JP, Lucas B, Andraud F, Hogrel JY, Bellivier F, Del Cul A et al (2008). Inter-hemispheric asymmetry of motor corticospinal excitability in major depression studied by transcranial magnetic stimulation. J Psychiatr Res 42: 389-398. (Pubitemid 351253576)
37. Levinson AJ, Fitzgerald PB, Favallli G, Blumberger DM, Daigle M, Daskalakis ZJ (2010). Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry 67: 458-464.
38. Licata SC, Jensen JE, Penetar DM, Prescot AP, Lukas SE, Renshaw PF (2009). A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T. Psychopharmacology 203: 819-829.
39. Lin Y, Stephenson MC, Wharton SJ, Xin L, Mougin OE, Napolitano A et al (2011). Investigating the metabolic changes due to visual stimulation using functional proton magnetic resonance spectroscopy at 7T. Proc Intl Soc Mag Reson Med 19: 311.
40. Littner M, Hirshkowitz M, Kramer M, Kapen S, Anderson WM, Bailey D et al (2003). Practice parameters for using polysomnography to evaluate insomnia: an update. Sleep 26: 754-760. (Pubitemid 39619788)
41. Luscher B, Shen Q, Sahir N (2011). The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 16: 383-406.
42. Maciag D, Hughes J, Dwyer G, Pride Y, Stockmeier CA, Sanacora G et al (2010). Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies. Biol Psychiatry 67: 465-470.
43. Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R (1998). Simulataneous in vivo spectral editing and water suppression. NMR Biomed 11: 266-272. (Pubitemid 28465190)
44. Montagna P (2005). Fatal familial insomnia: a model disease in sleep physiopathology. Sleep Med Rev 9: 339-353. (Pubitemid 41243211)
45. Morin CM (1993). Insomnia: Psychological Assessment and Management. Guilford Press: New York.
46. Morin CM, Vallières A, Ivers H (2007). Dysfunctional beliefs and attitudes about sleep (DBAS): validation of a brief version (DBAS-16). Sleep 30: 1547-1554. (Pubitemid 350036980)
47. Neckelmann D, Mykletun A, Dahl AA (2007). Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 30: 873-880. (Pubitemid 47041390)
48. Nierenberg AA, Husain MM, Trivedi MH, Fava M, Warden D, Wisniewski SR et al (2010). Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med 40: 41-50.
49. Nofzinger EA, Buysse DJ, Germain A, Price JC, Miewald JM, Kupfer DJ (2004). Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry 161: 2126-2128.
50. Nofzinger EA, Nissen C, Germain A, Moul D, Hall M, Price JC et al (2006). Regional cerebral metabolic correlates of WASO during NREM sleep in insomnia. J Clin Sleep Med 2: 316-322. (Pubitemid 44299556)
51. Ohayon MM, Roth T (2003). Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 37: 9-15. (Pubitemid 35449766)
52. Périco CA, Skaf CR, Yamada A, Duran F, Buchpiguel CA, Castro CC et al (2005). Relationship between regional cerebral blood flow and separate symptom clusters of major depression: a single photon emission computed tomography study using statistical parametric mapping. Neurosci Lett 384: 265-270. (Pubitemid 40836012)
53. Petty F, Schlesser MA (1981). Plasma GABA in affective illness. A preliminary investigation. J Affect Disord 3: 339-343. (Pubitemid 12248167)
54. Price RB, Shungu DC, Mao X, Nestadt P, Kelly C, Collins KA et al (2009). Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder. Biol Psychiatry 65: 792-800.
55. Provencher SW (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30: 672-679. (Pubitemid 23360802)
56. Provencher SW (2001). Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 14: 260-264. (Pubitemid 32611437)
57. Rajkowska G, O'Dwyer G, Teleki Z, Stockmeier CA, Miguel-Hidalgo JJ (2007). GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 32: 471-482. (Pubitemid 46106953)
58. Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M et al (2010). The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 14: 19-31.
59. Sanacora G (2010). Cortical inhibition, gamma-aminobutyric acid, and major depression: there is plenty of smoke but is there fire? Biol Psychiatry 67: 397-398.
60. Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL et al (2004). Subtype-specific alterations of gammaaminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61: 705-713. (Pubitemid 38890805)
61. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA et al (1999). Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56: 1043-1047. (Pubitemid 29526389)
62. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB et al (2003). Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 160: 577-579. (Pubitemid 41094271)
63. Saper C, Scammell T, Lu J (2005). Hypothalamic regulation of sleep and circadian rhythms. Nature 437: 1257-1263. (Pubitemid 41568665)
64. Simon GE, VonKorff M (1997). Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 154: 1417-1423. (Pubitemid 27415610)
65. Smith MT, Perlis ML, Chengazi VU, Pennington J, Soeffing J, Ryan JM et al (2002). Neuroimaging of NREM sleep in primary insomnia: a Tc-99-HMPAO single photon emission computed tomography study. Sleep 25: 325-335. (Pubitemid 34496413)
66. Steriade M (2003). The corticothalamic system in sleep. Front Biosci 8: D878-D899. (Pubitemid 38943170)
67. Szklo-Coxe M, Young T, Peppard PE, Finn LA, Benca RM (2010). Prospective associations of insomnia markers and symptoms with depression. Am J Epidemiol 171: 709-720.
68. Villablanca J, Salinas-Zeballos M (1972). Sleep-wakefulness, EEG and behavioral studies of chronic cats without the thalamus-the 'athalamic cat. Arch Ital Biol 110: 383-411.
69. Weissman MM, Greenwald S, Nino-Murcia G, Dement WC (1997). The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 19: 245-250. (Pubitemid 27400826)
70. Winkelman JW, Buxton OM, Jensen JE, Benson KL, O'Connor SP, Wang W et al (2008). Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS). Sleep 31: 1499-1506.
71. Winkelman JW, Finn L, Young T (2006). Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 7: 545-552. (Pubitemid 44480745)